Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-12

FDA Approved: IBSRELA — Original Application (Ardelyx, Inc.)

View source ↗

Summary

The FDA approved IBSRELA (tenapanor hydrochloride) in an original NDA for the treatment of irritable bowel syndrome with constipation. This marks the introducti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IBSRELA (tenapanor hydrochloride)

Snippet

ORIG AP for IBSRELA (TENAPANOR HYDROCHLORIDE)